Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward.
about
Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activityAn IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injuryPathological and protective roles of glia in chronic painThe "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting gliaProinflammatory cytokines oppose opioid-induced acute and chronic analgesiaMetaplasticity and behavior: how training and inflammation affect plastic potential within the spinal cord and recovery after injuryMedications development for opioid abuseTargeting Toll-like receptors with small molecule agentsGlial modulators: a novel pharmacological approach to altering the behavioral effects of abused substancesOpioid-induced central immune signaling: implications for opioid analgesiaGlutamatergic transmission in drug reward: implications for drug addictionEvidence that opioids may have toll-like receptor 4 and MD-2 effectsPossible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequencesNon-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)Ceasing intrathecal therapy in chronic non-cancer pain: an invitation to shift from biomedical focus to active managementToll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence.Acute morphine alters GABAergic transmission in the central amygdala during naloxone-precipitated morphine withdrawal: role of cyclic AMP.The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.Neonatal Escherichia coli infection alters glial, cytokine, and neuronal gene expression in response to acute amphetamine in adolescent ratsGabapentin improves cold-pressor pain responses in methadone-maintained patients.The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.Pathological pain and the neuroimmune interface.Validation of a preclinical spinal safety model: effects of intrathecal morphine in the neonatal ratToll-like receptor 4 in CNS pathologiesNew directions in migraineInflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms.Increased responsiveness of peripheral blood mononuclear cells to in vitro TLR 2, 4 and 7 ligand stimulation in chronic pain patientsEssential role of toll-like receptor 2 in morphine-induced microglia activation in miceCodeine-induced hyperalgesia and allodynia: investigating the role of glial activationHysterectomy and predictors for opioid prescription in a chronic pain clinic sample.Chronic morphine-induced microRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6.Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strainsToll-like receptor 4 is a regulator of monocyte and electroencephalographic responses to sleep loss.Dose escalation during the first year of long-term opioid therapy for chronic painMolecular and contextual markers of hepatitis C virus and drug abuse.Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression.Therapeutic Developments Targeting Toll-like Receptor-4-Mediated NeuroinflammationSex differences in motivational responses to dietary fat in Syrian hamsters
P2860
Q24612607-3A6FAF33-FA8F-47F3-AE5D-F6D0E589DEEDQ24634101-931486D6-9AED-405F-9E5B-16145D31CC27Q24646738-8174653B-4DE7-464D-B389-039DF4B12CF4Q24650739-3F22DDE8-C1B9-48F4-B9D8-1F75E400C285Q24650758-C2B8AFBC-32E8-43CA-86B7-A1F8748A9D3AQ26828742-3DC96A8A-A497-4889-A6A1-DA1CD962A9B4Q26853370-7AA95190-20D6-4688-9DAC-E64A5B1875F4Q26992220-B378E6DA-934D-445C-AAC8-B0FA0C4698A4Q27003932-26CB01C1-738D-40B8-8A72-F5E5ECFA4582Q27021477-DE1F0E02-FF54-4A6A-A374-7777656626B5Q28112161-64104FF7-EDE4-4445-AE0A-E89793984358Q28254885-C3C49896-A706-43A8-A5EB-0C22E4A121B8Q28274052-FC74CCB0-F055-4E81-BC53-07E8F011BCB5Q28288846-52F6A200-AECC-44FC-ABD3-97642A434012Q28485070-75A3A2DB-A3BB-42F6-B43F-13F948001D28Q33604982-00D90E0D-ED6D-4273-AA96-C8687DE47401Q33709318-EB41CCDA-C6B3-4C3B-8863-6EC0C6DE65DBQ33727021-DBAB8206-7C4E-40F2-B8E6-D7099F8C1316Q33834882-F9F52EA5-FF5F-452A-AE8E-4054FE765941Q33872764-4D7BA791-2DE4-430D-9E8C-9F724353A6F6Q33886313-37C0F036-7C21-41BE-A527-CAD9E1BCD098Q33925677-50D7424B-CC4B-4E75-8A7A-BF3999379FD4Q33987944-F4ADA00B-85E5-4A70-A8AC-EE4CD00008DBQ34018705-346E634B-CC43-4BE6-8CE1-EAD3E8B98AE0Q34057763-ED0422DB-A285-48B7-948B-E97A12A92B0FQ34199534-45F3912C-7157-44ED-9629-412CBB56E007Q34399714-65AD4DCE-C376-43E7-B527-24708F7B528FQ34478755-6F227E0E-F69E-4D57-A009-CC988D0F4493Q34658014-45F1010E-A20E-413D-BD91-63CC8F6831C8Q34789109-2998C241-1915-4706-B0A3-56FD9C70F9DFQ34980268-35938ADE-A77A-494C-995F-4C5E0DCDAB88Q35087100-936109E4-6BE4-4B1E-8301-4ECC62F6AB45Q35122783-95D11F78-729D-4755-B9D0-6CD47A9150C1Q35124986-062425C9-C467-46C6-A2DE-AE638AD019A5Q35217760-8E8DF1B3-3C05-41E3-B967-CB69A7937EAFQ35327472-C451A2E4-6546-4288-9135-6EA6A947785CQ35660841-0B17DCE6-5B01-4FB3-851A-05796B8085B8Q35676825-EF360305-83B2-4D5E-83EC-1523FE139348Q35681383-8E5CA937-070C-4D87-A687-7DF4AD7152C6Q35685251-1F1A521C-6C01-4691-80FA-EEFED825AABB
P2860
Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Opioid-induced glial activatio ...... gesia, dependence, and reward.
@en
Opioid-induced glial activatio ...... gesia, dependence, and reward.
@nl
type
label
Opioid-induced glial activatio ...... gesia, dependence, and reward.
@en
Opioid-induced glial activatio ...... gesia, dependence, and reward.
@nl
prefLabel
Opioid-induced glial activatio ...... gesia, dependence, and reward.
@en
Opioid-induced glial activatio ...... gesia, dependence, and reward.
@nl
P2093
P921
P356
P1476
Opioid-induced glial activatio ...... gesia, dependence, and reward.
@en
P2093
Kenner C Rice
Kirk W Johnson
Sondra T Bland
Steven F Maier
P304
P356
10.1100/TSW.2007.57
P407
P577
2007-11-02T00:00:00Z